Compugen Ltd. (CGEN)
NASDAQ: CGEN · IEX Real-Time Price · USD
1.05
+0.02 (1.94%)
Jun 2, 2023, 4:00 PM EDT - Market closed
Compugen Market Cap
Compugen has a market cap or net worth of $90.96 million as of June 2, 2023. Its market cap has decreased by -39.20% in one year.
Market Cap
90.96M
Enterprise Value
18.43M
1-Year Change
-39.20%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $90.96M, an increase of 95.60%. That is a compound annual growth rate of 3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2023 | 89.20M | 0.90% |
| May 31, 2023 | 88.40M | -3.70% |
| May 30, 2023 | 91.80M | - |
| May 26, 2023 | 91.80M | 10.60% |
| May 25, 2023 | 83.00M | 2.98% |
| May 24, 2023 | 80.60M | 13.36% |
| May 23, 2023 | 71.10M | 2.60% |
| May 22, 2023 | 69.30M | 5.32% |
| May 19, 2023 | 65.80M | - |
| May 18, 2023 | 65.80M | -1.20% |
| May 17, 2023 | 66.60M | -0.15% |
| May 16, 2023 | 66.70M | -5.39% |
| May 15, 2023 | 70.50M | 9.98% |
| May 12, 2023 | 64.10M | -1.38% |
| May 11, 2023 | 65.00M | - |
| May 10, 2023 | 65.00M | 12.07% |
| May 9, 2023 | 58.00M | 0.69% |
| May 8, 2023 | 57.60M | 5.49% |
| May 5, 2023 | 54.60M | - |
| May 4, 2023 | 54.60M | 0.18% |
| May 3, 2023 | 54.50M | 3.22% |
| May 2, 2023 | 52.80M | 7.98% |
| May 1, 2023 | 48.90M | -4.31% |
| Apr 28, 2023 | 51.10M | 0.39% |
| Apr 27, 2023 | 50.90M | -0.39% |
View and export this data all the way back to 2002.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics Inc. | 2.41B |
| Mirati Therapeutics, Inc. | 2.12B |
| Sana Biotechnology, Inc. | 1.13B |
| VectivBio Holding AG | 1.03B |
| Allogene Therapeutics, Inc. | 745.98M |
| Editas Medicine, Inc. | 614.75M |
| iTeos Therapeutics, Inc. | 581.16M |
| Icosavax, Inc. | 434.98M |
| Caribou Biosciences, Inc. | 265.70M |
| Annexon, Inc. | 148.63M |
| BioLineRx Ltd. | 95.06M |
| CollPlant Biotechnologies Ltd. | 83.11M |
| Surface Oncology, Inc. | 48.57M |
| ImmuCell Corporation | 39.20M |
| Pluri Inc. | 33.72M |
| Evogene Ltd. | 24.98M |
| BiomX Inc. | 15.31M |
| Can-Fite BioPharma Ltd. | 10.44M |